Opportunity

DIBBS #SPE2DP-26-T-2710

DLA Solicitation for Moxifloxacin Hydrochloride Tablets (400 mg, 30-count)

Posted

April 08, 2026

Respond By

April 13, 2026

Identifier

SPE2DP-26-T-2710

NAICS

325412

This procurement opportunity from the Defense Logistics Agency (DLA) seeks Moxifloxacin Hydrochloride pharmaceuticals for military use. - Government Buyer: - Defense Logistics Agency (DLA), DLA Troop Support Medical Supply Chain Pharm FSA - Contracting office: Buyer Code DMT0026 - Approved OEMs/Manufacturers: - TEVA PHARMACEUTICALS USA, INC. (NDC00093-7387-56) - DR REDDY'S LABORATORIES, INC. (NDC55111-0112-30) - RISING PHARMA HOLDINGS, INC. (NDC57237-0156-30) - Products Requested: - Moxifloxacin Hydrochloride Tablets, 400 mg, 30 tablets per bottle - National Stock Number (NSN): 6505-01-503-4772 - Total quantity: 2 bottles (1 per line item) - Delivery Locations: - Fort Carson, Colorado (US military base) - US Army SSA 173rd Brigade, Vicenza, Italy (US military base) - Notable Requirements: - Packaging and marking must comply with MIL-STD-2073-1E and Medical Marking Standard No. 1 - Compliance with Buy American Act, Berry Amendment, and NIST SP 800-171 cybersecurity standards - Delivery required within 10 calendar days from award - No additional technical attachments or unique requirements beyond standard pharmaceutical and packaging compliance

Description

MOXIFLOXACIN HYDROC (QTY: 1, NSN: 6505-01-503-4772, Purchase Request: 7016223548) Approved Sources: - CAGE: 3V8D7, Part No: NDC00093-7387-56, Company: TEVA PHARMACEUTICALS USA, INC. - CAGE: 4E8M8, Part No: NDC55111-0112-30, Company: DR REDDY'S LABORATORIES, INC. - CAGE: 8FG82, Part No: NDC57237-0156-30, Company: RISING PHARMA HOLDINGS, INC.

MOXIFLOXACIN HYDROC (QTY: 1, NSN: 6505-01-503-4772, Purchase Request: 7016240771) Approved Sources: - CAGE: 3V8D7, Part No: NDC00093-7387-56, Company: TEVA PHARMACEUTICALS USA, INC. - CAGE: 4E8M8, Part No: NDC55111-0112-30, Company: DR REDDY'S LABORATORIES, INC. - CAGE: 8FG82, Part No: NDC57237-0156-30, Company: RISING PHARMA HOLDINGS, INC.

View original listing